122993-59-3

Basic information

• Product Name: 2-METHYLISOINDOLIN-4-AMINE
• Synonyms: 2-METHYLISOINDOLIN-4-AMINE;OTAVA-BB 1088246;2,3-dihydro-2-Methyl-1H-Isoindol-4-aMine
• CAS NO: 122993-59-3
• Molecular Formula: C₉H₁₂N₂
• Molecular Weight: 148.21
• Mol File: 122993-59-3.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 250.7±40.0 °C(Predicted)
• Appearance: /
• Density: 1.123±0.06 g/cm3(Predicted)
• PKA: 7.79±0.20(Predicted)
• CAS DataBase Reference: 2-METHYLISOINDOLIN-4-AMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-METHYLISOINDOLIN-4-AMINE(122993-59-3)
• EPA Substance Registry System: 2-METHYLISOINDOLIN-4-AMINE(122993-59-3)

Safety Data

• Hazardous Substances Data: 122993-59-3(Hazardous Substances Data)

Usage

General Description

2-Methylisoindolin-4-amine is a chemical compound with the molecular formula C9H10N2. It is a heterocyclic amine with a methyl group attached to the isoindoline ring. 2-METHYLISOINDOLIN-4-AMINE is used as a building block in organic synthesis and pharmaceutical research, as well as in the production of dyes and pigments. It is also known for its potential application in the development of new materials and drug molecules. Its unique structure and properties make it a valuable tool in the field of chemical and pharmaceutical sciences.

Upstream product

• 2593-81-9 N-methyl-3-nitrophthalimide 
• 2257-85-4 4-amino-2-methyl-1H-isoindole-1,3(2H)-dione 

Relevant articles and documents

NOVEL QUINOXALINEDIONE DERIVATIVES, THEIR PREPARATION AND USE

A compound having the formula or a pharmaceutically acceptable salt thereof wherein R is hydrogen or hydroxy; R1 is hydrogen, alkyl, arylalkyl, (CH2)nOH, or (CH2) NR7R8; R5 and R6 are each independently hydrogen, halogen, NO2, CN, CF3, SO2NR7R8, PO3R9R10, alkyl, alkenyl, alkynyl, (CH2)nCONR7R8, (CH2)nCO2R10, NHCOR11, wherein R7 and R8 are each independently hydrogen or alkyl or together R7 and R8 form a ring of from three to seven atoms, R9 is hydrogen or alkyl, R10 is hydrogen or alkyl, R11 is hydrogen or alkyl, and n is an integer of from zero to four; A is a ring of five to seven atoms fused with the benzo ring at the positions marked a and b, and formed by the following bivalent radicals: a-NR12—CHR13—CHR14-b, a-CHR13—CHR14—NR12-b, a-CHR13—NR12—CHR14-b, a-CHR14—CH2—NR12—CHR13-b, a-CHR13—NR12—CH2—CHR14-b, a-CH2—CH2—CHR13—NR12-b, a-NR12—CHR12—CHR13—CH2—CH2-b, a-CH2—CH2—NR12—CH2—CH2-b, a-CH2—CH2—CH2NR12—CH2-b, a-CH2—NR12—CH2—CH2-b a-CH2—CH2—CH2—CH2—NR12-b, a-NR12—CH2—CH2—CH2—CH2-b, wherein R12 is hydrogen, CH2CH2OH, or alkyl, and R13 and R14 are each independently hydrogen, CN, CONH2, CH2NH2, CH2OH, alkyl, arylalkyl, alkenyl, or CO2R15, wherein R15 is hydrogen or alkyl. The compounds are useful in the treatment of disorders of mammals, responsive to the blockade of glutamic and aspartic acid receptors. Processes for preparing the compounds and novel intermediate useful in the processes are also included.